AD Clinical Trials in Plain Language

Clinical trials for AD explained in plain language.

Never miss a new study

Get alerted when new AD trials appear

Sign up with your email to follow new studies for AD, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 1 Terminated 1

New pill aims to slow Alzheimer's in early stages

Disease control Recruiting now

This study tests a new tablet called TTYP01 in people with early Alzheimer's (mild memory problems or mild dementia). About 180 participants will receive either a low dose, high dose, or placebo for 78 weeks. The goal is to see if the drug can slow down memory decline and reduce …

Matched conditions: AD

Phase: PHASE2 • Sponsor: Shanghai Auzone Biological Technology Co., Ltd. • Aim: Disease control

Last updated May 15, 2026 11:58 UTC

AD

Get alerted when new AD trials appear

New pill aims to slow Alzheimer's in early stages